- Clone
- A22124B (See other available formats)
- Regulatory Status
- RUO
- Other Names
- S100 Calcium-binding protein A8, Cystic Fibrosis Antigen (CFAG), Calgranulin A (CAGA, CGLA), Myeloid-related protein 8 (MRP8), S10A8
- Isotype
- Mouse IgG1, κ
- Ave. Rating
- Submit a Review
- Product Citations
- publications
-
Human peripheral blood mononuclear cells were fixed and permeabilized with Cyto-Fast™ Fix/Perm Buffer (Cat. No. 426803) and intracellularly stained with purified anti-human S100A8 (clone A22124B) (left) or purified mouse IgG1, κ isotype control (right), followed by anti-mouse IgG PE. Cells were then stained with anti-human CD14 (clone HCD14) Pacific Blue™. -
Human peripheral blood granulocytes were fixed and permeabilized with Cyto-Fast™ Fix/Perm Buffer (Cat. No. 426803) and intracellularly stained with purified anti-human S100A8 (clone A22124B) (left) or purified mouse IgG1, κ isotype control (right), followed by anti-mouse IgG PE. Cells were then stained with anti-human CD15 (clone W6D3) Pacific Blue™.
| Cat # | Size | Price | Quantity Check Availability | Save | ||
|---|---|---|---|---|---|---|
| 377103 | 100 µg | 332€ | ||||
S100A8 is a member of the S100/calgranulin family of proteins containing 2EF-hand calcium-binding motifs. S100A8 is mainly expressed in cells of the myeloid lineage and is present in circulating neutrophils and monocytes. S100A8 expression is also transiently induced in keratinocytes after epidermal injury and in psoriasis where pro-inflammatory cytokines induce its expression. S100A8 is mostly cytoplasmic, but can be translocated to the plasma membrane or released into the extracellular environment upon cellular activation. S100A8 preferentially interacts with S100A9 to form a heterodimer S100A8/A9, also known as calprotectin. S100A8/A9 functions as a danger associated molecular pattern (DAMP) molecule and stimulates innate immune cells via binding to pattern recognition receptors such as Toll-like receptor 4 (TLR4) and receptor for advanced glycation end products (AGER). Binding to TLR4 and AGER activates the MAP-kinase and NF-kappa-B signaling pathways resulting in the amplification of the proinflammatory cascade. The extracellular functions of S100A8/A9 also include the recruitment of leukocytes, promotion of cytokine and chemokine production, and regulation of leukocyte adhesion and migration. S100A8/A9 displays apoptosis-inducing activity against various tumor cells and also has antimicrobial activity by depriving bacterial pathogens of essential trace metals such as Zn2+ and Mn2+.
Product DetailsProduct Details
- Verified Reactivity
- Human, Rat, Mouse
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- Recombinant fragment of human S100A8
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
- Preparation
- The antibody was purified by affinity chromatography.
- Concentration
- 0.5 mg/mL
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C.
- Application
-
ICFC - Quality tested
- Recommended Usage
-
Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per million cells in 100 µL volume. It is recommended that the reagent be titrated for optimal performance for each application.
- RRID
-
AB_3717176 (BioLegend Cat. No. 377103)
Antigen Details
- Structure
- Homodimer
- Distribution
-
Neutrophils, monocytes, keratinocytes
- Function
- Pro-inflammatory molecule
- Interaction
- Neutrophils, monocytes
- Ligand/Receptor
- Toll-like receptor 4 (TLR4) and receptor for advanced glycation end products (AGER)
- Biology Area
- Immunology
- Antigen References
-
- Bhardwaj RS, et al. 1992. Eur. J. Immunol. 22:1891.
- Hunter MJ, et al. 1998. J. Biol. Chem. 273:12427.
- Hofmann MA, et al. 1999. Cell. 97:889-901.
- Cross SS, et al. 2005. Histopathology. 46:256.
- Zenz R, et al. 2005. Nature. 437:369.
- Hermani A, et al. 2006. Exp. Cell Res. 312:184.
- Vogl T, et al. 2007. Nature Med. 13:1042.
- Benedyk M, et al. 2007. J. Invest. Dermatol. 127:2001.
- Corbin BD, et al. 2008. Science. 319:962.
- Gebhardt C, et al. 2008. J. Exp. Med. 205:275.
- Loser K, et al. 2010. Nat Med. 16:713-17.
- Kang JH, et al. 2015. Immunology. 144:79-90.
- Gene ID
- 6279 View all products for this Gene ID
- UniProt
- View information about S100A8 on UniProt.org
Related Pages & Pathways
Pages
Related FAQs
Other Formats
View All S100A8 Reagents Request Custom Conjugation| Description | Clone | Applications |
|---|---|---|
| Purified anti-S100A8 | A22124B | ICFC |
| PE anti-S100A8 | A22124B | ICFC |
Compare Data Across All Formats
This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.
Login / Register 


Follow Us